Event Date/Time: Nov 25, 2009
End Date/Time: Nov 26, 2009
More than 26 million people worldwide were estimated to be living with Alzheimer's disease in 2006, and it is estimated that the global prevalence of Alzheimer's disease will grow to more than 106 million by 2050. SMiâ€™s 8th annual event on Clinical Trials in CNS, will look at new advances in the treatment of this disorder of the central nervous system, as well as examining others.
Experts will consider emerging disease targets, use of biomarkers and imaging techniques in clinical trials, cognitive testing, translational medicine, as well as safety and regulatory issues. There will also be an update on progress of the recent Alzheimer's Disease Neuroimaging Initiative (ADNI).
Why should you attend this event?
â€¢ GAIN insight into appropriate safety measures
â€¢ HEAR the latest progress of ADNI
â€¢ UNDERSTAND how to design better CNS trials
â€¢ EVALUATE different end-point methods
â€¢ DISCOVER recent advances in disease method understanding and target identification
PLUS HALF DAY ASSOCIATED PRE-CONFERENCE WORKSHOP
Effective Project Management in Clinical Trials
24th November 2009-06-25 Crown Plaza Hotel, London
In association with: Metanaction
To register online visit: www.smi-online.co.uk/09cnstrials.asp
Alternatively contact Vicky Bull Tel. +44 (0) 20 7827 6158 or e-mail: email@example.com
Academic and Group Discounts Available!!